Integrative analysis identifies potential DNA methylation biomarkers for pan-cancer diagnosis and prognosis
DNA methylation status is closely associated with diverse diseases, and is generally more stable than gene expression, thus abnormal DNA methylation could be important biomarkers for tumor diagnosis, treatment and prognosis. However, the signatures regarding DNA methylation changes for pan-cancer di...
Main Authors: | Wubin Ding, Geng Chen, Tieliu Shi |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2019-01-01
|
Series: | Epigenetics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/15592294.2019.1568178 |
Similar Items
-
DNA methylation loci identification for pan-cancer early-stage diagnosis and prognosis using a new distributed parallel partial least squares method
by: Qi-en He, et al.
Published: (2022-10-01) -
CancerClock: A DNA Methylation Age Predictor to Identify and Characterize Aging Clock in Pan-Cancer
by: Tongtong Zhu, et al.
Published: (2019-12-01) -
Pan-cancer landscape of aberrant DNA Methylation across childhood Cancers: Molecular Characteristics and Clinical relevance
by: Zheng Dong, et al.
Published: (2022-11-01) -
Gelsolin: A comprehensive pan-cancer analysis of potential prognosis, diagnostic, and immune biomarkers
by: Yiyang Wang, et al.
Published: (2023-03-01) -
Tubulin alpha-1b chain was identified as a prognosis and immune biomarker in pan-cancer combing with experimental validation in breast cancer
by: Yiyang Wang, et al.
Published: (2024-04-01)